Effect exercise during hemodialysis on blood level of Parathyroid hormone, Calcium, Phosphate and Albumin patients undergoing hemodialysis

Not Applicable

• Conditions: Chronic kidney disease.; Chronic kidney disease, stage 5; N18.5

• Registration Number: IRCT20150116020675N4
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age between 18 and 65 years old
Having full consciousness and being able to listen and speak to answer to questions
History of hemodialysis at least 3 months
Not having cardiac ischemia, MI and Cardiac angina over last three months
Not having severe pulmonary disease
Not having history of CVA or ischemic attack over last three months
Not having any skeletal muscular disease that prevents patients from doing exercise
The patients are treated with hemodialysis three times a week (4 hours)
Not having history of parathyroidectomy surgery
Not having physical and mental disability

Exclusion Criteria

Not having tendency to continue participating in the study in any stage of the study
Suffering from cardiovascular, pulmonary diseases and any disorder that prevents the patient from doing exercise during the study.
Not doing exercise for two consecutive sessions or four non-consecutive sessions

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The level of parathyroid hormone in blood. Timepoint: At the beginning of the study and 8 weeks after the beginning of the intervention. Method of measurement: Blood Test.

Secondary Outcome Measures

Name	Time	Method
The levels of Calcium of blood. Timepoint: At the beginning of the study and 8 weeks after the beginning of the intervention. Method of measurement: Blood test.;The level of phosphorus of blood. Timepoint: At the beginning of the study and 8 weeks after the beginning of the intervention. Method of measurement: Blood test.;The level of Albumin of blood. Timepoint: At the beginning of the study and 8 weeks after the beginning of the intervention. Method of measurement: Blood test.